Payal Shah Patel
About Payal Shah Patel
Payal Shah Patel is the Vice President and Head of Cellular Therapy, Clinical Science at Bristol Myers Squibb, with over a decade of experience in clinical research and medical sciences.
Title
Payal Shah Patel is currently serving as the Vice President and Head of Cellular Therapy, Clinical Science at Bristol Myers Squibb. She has been leading this division since November 2021, based in Summit, New Jersey, United States.
Previous Roles at Bristol Myers Squibb
Before becoming Vice President, Payal Shah Patel worked at Bristol Myers Squibb as the Senior Director, Program Lead CRS - Cellular Therapy. She held this role from 2016 to 2021, contributing five years of her expertise to the company.
Previous Roles at Merck
Prior to her tenure at Bristol Myers Squibb, Payal Shah Patel was at Merck where she served as a Senior Clinical/Medical Research Scientist, focusing on oncology research from 2013 to 2016. She also worked as a Clinical Research Specialist in Vaccines from 2011 to 2013 in Upper Gwynedd, PA.
Early Career and Research Internships
Payal Shah Patel's career began as a Research Intern at New Jersey Medical School, where she worked from 2004 to 2006. This early experience set the foundation for her extensive career in clinical research and medical sciences.
Education and Expertise
Payal Shah Patel holds a Master’s Degree in Medical Clinical Sciences/Graduate Medical Studies from the University of Medicine and Dentistry of New Jersey. Her academic background has significantly contributed to her expertise in clinical research and medical sciences, including vaccines and oncology.